HIGHLIGHTS
RECENT PUBLICATIONS
JAN 2019 Hepatology Communications Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People who inject drugs and/or those in Opioid Agonist Therapy
DEC 2018 Canadian Liver J Contextualizing Canada’s hepatitis C virus epidemic
NOV 2018 J of Viral Hepatitis Applying core therapy and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia Canada
NOV 2018 Eclinical Medicine Syndemic chrachterizations of HCV, HBV, and HIV co-infections in a large population based cohort study
JUL 2018 J of Viral Hepatitis Estimating the imopact if early hepatitis C virus clearance in hepatocellulr carcinoma risk
AUG 2018 Dove Press Effect of opioid-subsitution therapy and mental health counseling on HIV risk among hepatitis C infected individuals
AUG 2018 J of Hepatol Hepatitis C virus after successful treatment with direct-acting antiviral therapy in a large population based cohort
MAR 2018 World J of Gastroenterology Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia
FEB 2018 Int J of drug policy Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
NEWS
February 2018 Canadian Liver Meeting- Poster of Distinction) 
October 2017 New research underlines need to develop a hepatitis C vaccine
September 2017 Fast Facts: Hepatitis C treatment cascade and development in access to treatment
August 2017 The availability of direct –acting antivirals is reducing disparities in the uptake of hepatitis C treatment
August 2017 Previously Cured HCV patients can be reinfected-prevention will require attention to high-risk behaviours
